ALGN

Align Technology Inc.

Price

$140.75

return (12m)

7.88%

p/e

25.13

p/bv

2.46

DIVIDEND YIELD

0.00%

ALGN price

Align Technology

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ALGN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-8.62%

3 months

-20.85%

1 year

7.88%

2 years

-40.07%

5 years

-78.13%

10 years

54.53%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals ALGN

Valuation

P/E

25.13

Sector 1.08

Industry 3.46

P/BV

2.46

Sector 1.86

Industry 2.13

P/Revenue (PSR)

2.51

Sector 1.54

Industry 1.72

EV/EBITDA

39.89

Sector -46.43

Industry 1.72

EV/EBIT

48.20

Sector -49.92

Industry -4.29

P/EBITDA

11.46

Sector -31.92

Industry -53.68

P/EBIT

15.93

Sector -43.90

Industry -50.97

P/Total Assets

1.62

Sector 0.85

Industry 0.96

P/Net Current Assets

21.74

Sector -25.98

Industry -11.19

P/Working Capital

13.77

Sector -3.94

Industry 2.92

EPS

5.78

Sector -0.70

Industry -0.60

BVPS

59.20

Sector 4.54

Industry 4.74

Efficiency

Gross Margin

68.05%

Sector 49.38%

Industry 50.68%

EBITDA Margin

22.05%

Sector -280.65%

Industry -57.47%

EBIT Margin

18.25%

Sector -163.23%

Industry -56.25%

Operating Margin

13.23%

Sector -19.46%

Industry -25.80%

Net Profit Margins

9.99%

Sector -23.67%

Industry -29.17%

Asset Turnover

0.16

Sector 0.13

Industry 0.15

Profitability

ROE

9.77%

Sector -23.63%

Industry -22.30%

ROA

6.44%

Sector -24.09%

Industry -24.15%

ROIC

11.34%

Sector -584.46%

Industry -96.49%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

1.40

Sector 1.90

Industry 1.98

Net Debt / EBITDA

-4.74

Sector -23.21

Industry -2.21

Net Debt / EBIT

-5.72

Sector -11.18

Industry -1.50

Net Debt / Equity

-0.26

Sector -0.63

Industry -0.29

Gross Debt / Equity

0.00

Sector -0.72

Industry -0.82

Equity/Assets

0.66

Sector 0.46

Industry 0.47

Liabilities/Assets

0.34

Sector 0.50

Industry 0.52

Growth

5Y Revenue CAGR

0.93%

Sector -

Industry -

5Y Earnings CAGR

-11.74%

Sector -

Industry -

Fundamentals ALGN

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Align Technology ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$140.75

Fair Value

$87.74

Upside

-37.66%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ALGN Align Technology Inc.	$140.75	7.03%	0.00%	25.13	2.46	9.77%	9.99%
ABT Abbott Laboratories	$98.66	-23.65%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$85.51	-9.58%	3.30%	21.10	2.17	10.29%	13.93%
BSX Boston Scientific Corp.	$42.34	-56.22%	0.00%	17.31	2.55	14.73%	17.49%
TMDX TransMedics Group Inc.	$81.07	-28.84%	0.00%	17.68	5.18	29.28%	22.69%
RMD ResMed Inc.	$225.98	-18.84%	1.12%	20.92	4.84	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$506.67	-19.29%	0.00%	36.04	25.47	70.67%	25.03%
COHR Coherent Inc.	$334.56	191.50%	0.00%	81.57	5.84	7.16%	11.31%
SYK Stryker Corp.	$275.40	-23.80%	1.27%	28.21	4.38	15.55%	14.43%
PHG Koninklijke Philips NV	$24.09	-10.70%	4.25%	17.60	1.72	9.80%	6.30%
INMD InMode Ltd.	$14.01	-8.01%	0.00%	10.69	1.32	12.32%	20.69%
BDX Becton Dickinson and Company	$180.16	-3.83%	2.39%	51.40	1.98	3.85%	6.29%
DXCM DexCom Inc.	$84.77	27.74%	0.00%	32.65	12.45	38.14%	20.12%
EW Edwards Lifesciences Corp.	$85.78	12.04%	0.00%	48.96	4.59	9.37%	15.43%
SNN Smith & Nephew PLC	$26.88	-22.52%	2.96%	19.66	4.27	21.74%	9.20%
IRMD iRadimed Corporation	$85.47	20.47%	1.49%	47.27	10.71	22.66%	26.70%
ZBH Zimmer Biomet Holdings Inc.	$88.49	-9.28%	1.10%	20.85	1.33	6.39%	9.48%
HSIC Henry Schein Inc.	$83.66	26.68%	0.00%	23.66	2.50	10.56%	2.96%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ALGN - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Align Technology

Align Technology Inc.

Average Investor10 user rating

4.0 (8 people)

United States

29 years

Founded: 1997

2001

Time since IPO - 25 years

23.000

Employees

Align Technology Inc. (United States) is listed on the Nasdaq and has a market capitalization of $10.39 billion, with shareholders equity totaling $4.23 billion.

The company employs approximately 23.000 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Align Technology Inc. reported $4.14 billion in revenue, generating net income of $413.58 million.

Key financial metrics include a P/E ratio of 25.13, a price-to-book (P/B) ratio of 2.46, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ALGN.

Market cap

$10.39 billion

Net worth

$4.23 billion

$4,232,453,000.00

Assets

$6.42 billion

$6,417,581,000.00

Total Shares Outstanding

71.50 million

71,495,000

Average Daily Trading Volume

$912.77 Thousand

$912,774.44

Sector

Health

Industry

Medical Supplies and Equipment

ALGN

ALGN revenue and profits

Financial Results ALGN

DRAG THE FRAME TO SEE MORE DATA

ALGN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$87.95 18,85% (12M)

P/E

22.49

3.09%

ROE

6.12%

P/BV

1.38

CI - Cigna

$278.51 --7,16% (12M)

P/E

10.33

2.31%

ROE

16.04%

P/BV

1.66

CNC - Centene

$64.99 69,02% (12M)

P/E

-6.05

0.00%

ROE

-22.53%

P/BV

1.36

HUM - Humana

$396.51 35,25% (12M)

P/E

35.89

0.93%

ROE

6.63%

P/BV

2.38

SNY - Sanofi

$40.20 --14,37% (12M)

P/E

3.72

4.45%

ROE

18.43%

P/BV

0.69

JNJ - Johnson & Johnson

$258.45 39,34% (12M)

P/E

29.27

2.06%

ROE

24.76%

P/BV

7.25

LLY - Eli Lilly

$1,188.72 41,45% (12M)

P/E

38.06

0.59%

ROE

78.84%

P/BV

30.01

HCA - HCA Healthcare

$439.17 3,52% (12M)

P/E

13.82

0.71%

ROE

-213.15%

P/BV

-29.45